Vascular Therapies, Inc.
Clinical trials sponsored by Vascular Therapies, Inc., explained in plain language.
-
New implant could keep dialysis lifelines open longer
Disease control CompletedThis study tested a special collagen implant coated with sirolimus (rapamycin) placed around a new dialysis fistula during surgery. The goal was to see if it helps the fistula become usable for dialysis sooner and stay working longer. About 269 people with advanced kidney disease…
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New implant could speed up dialysis fistula maturation
Disease control CompletedThis phase 3 trial tests a sirolimus-releasing collagen implant placed around a new dialysis fistula during surgery. The goal is to help the fistula mature faster so it can be used for dialysis. The study involves 136 people aged 65+ with kidney failure who are new to hemodialysi…
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC